Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: QTIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The QT Imaging Holdings, Inc. (QTIH) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports, registration statements, and related exhibits. QT Imaging is a medical device company in the healthcare sector that develops and commercializes body imaging systems using low frequency sound waves, and its filings offer detailed insight into its capital structure, financing arrangements, and operational progress.
Investors can review Form 8-K current reports where QT Imaging discloses material events such as private placement (PIPE) financings, warrant repurchases, amendments to credit agreements, and the implementation of a 3:1 reverse stock split of its common stock. Certain 8-K filings also furnish unaudited pro forma condensed consolidated financial statements, which show how transactions like the September 2025 private placement and subsequent debt repayments affect the company’s balance sheet and statements of operations.
The company has filed a Form S-1 registration statement and an amended Form S-1/A, which contain information about its securities, historical financial statements, and various equity and debt instruments, including warrants, convertible notes, bridge loans, and earnout arrangements. These documents, together with other periodic and transactional filings, outline QT Imaging’s status as an emerging growth company and describe key elements of its financing history and customer concentration.
On Stock Titan, these filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries help explain the significance of complex disclosures, highlighting items such as changes to rights of security holders, reverse stock split mechanics, private placement terms, and pro forma adjustments. Users can quickly locate quarterly and annual financial information within registration statements, track capital markets actions, and examine how QT Imaging reports on its imaging business, cloud platform development, and related risks in its official SEC documents.
QT Imaging Holdings, Inc. implemented a reverse stock split of its common stock at a 3:1 ratio. The Certificate of Amendment became effective at 4:01 p.m. Eastern Time on October 23, 2025.
The company’s common stock will begin trading on the OTCQB Venture Market on a reverse split‑adjusted basis on October 24, 2025. Stockholders previously approved a reverse split within a 2:1 to 20:1 range, and the board set the final ratio at 3:1.
QT Imaging Holdings, Inc. announced a reverse stock split of its common stock at a 3:1 ratio. The split will be effective at 4:01 p.m. Eastern Time on October 23, 2025, after which the stock is expected to begin trading on the OTCQB Venture Market on a reverse split–adjusted basis on October 24, 2025. The common stock’s CUSIP will change to 746962307.
Stockholders previously approved a reverse split within a 2:1 to 20:1 range at the August 19, 2025 Annual Meeting, authorizing the board to set the final ratio. The company also disclosed it has submitted an application to relist on the Nasdaq Capital Market and issued a press release on October 20, 2025 detailing these plans.
QT Imaging Holdings, Inc. filed unaudited pro forma condensed consolidated financial information for the six months ended June 30, 2025. This pro forma presentation shows how the company’s balance sheet and results of operations would look if two previously disclosed financing transactions had occurred earlier in the year.
The first transaction is a private placement of securities under a Securities Purchase Agreement dated September 30, 2025, which generated aggregate gross proceeds of approximately
QT Imaging Holdings disclosed terms of subscription and pre-funded warrants issued in a private placement and related registration rights. The Subscription Warrants include standard adjustments for stock splits and similar events and provide that, in a Fundamental Transaction, holders may receive alternate consideration in the form and proportion offered to common stockholders. The company may, at a holder's option, purchase unexercised portions of Subscription Warrants for cash equal to the Black Scholes value; if the Fundamental Transaction is not within the company's control, holders receive the same form of consideration offered to common stockholders.
The Pre-Funded Warrants are exercisable for 5,424,083 shares of common stock at $0.0001 per share and expire upon full exercise. Under the Registration Rights Agreement entered with purchasers, the company must file a registration statement for resale of registrable securities within 30 days and have it declared effective as promptly as practicable, and in any event within 90 days (or 120 days if the SEC conducts a full review).